Archived News Headlines
We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.
Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.
Prometheus Laboratories Inc. Launches PROCLIVITY(SM) 01 Clinical Trial of Proleukin(R) (Aldesleukin for Injection) Plus Vemurafenib Therapy in Patients with Metastatic Melanoma
(Yahoo! Finance) May 9, 2013 - Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announces that PROCLIVITY 01, a multi-center study of Proleukin(R) (High Dose Interleukin-2 (HD IL-2))[1] plus vemurafenib therapy in patients with BRAF V600 mutation-positive metastatic melanoma (mM) is enrolling patients.
read article 
Microscopic Star-Shaped Grippers Take Biopsies
(NIH Research Matters) May 6, 2013 - Researchers designed and tested star-shaped microtools that close in response to body heat to grasp tissue samples. The microgrippers, which require no wires or power, can potentially be used to retrieve tissue samples in many hard-to-reach places.
read article
Research Reveals Cancer-Suppressing Protein 'Multitasks'
(Walter + Eliza Hall) May 5, 2013 - The understanding of how a powerful protein called p53 protects against cancer development has been upended by a discovery by Walter and Eliza Hall Institute researchers.
read press release
Scientists Define a New Mechanism Leading to Tumor Hypoxia
(Versita) May 9, 2013 - An article published recently in "Tumor Microenvironment and Therapy" - an open access journal by Versita, defines a novel mechanism of tumor hypoxia induced by the longitudinal gradient of residual oxygen along tumor vessels as they transverse the tumor.
read press release
Your Immune System: On Surveillance in the War Against Cancer
(Wake Forest Bapist Medical Center) May 9, 2013 - Predicting outcomes for cancer patients based on tumor-immune system interactions is an emerging clinical approach, and new research from Wake Forest Baptist Medical Center is advancing the field when it comes to the most deadly types of breast cancer.
read press release
Researchers Develop New Technique to Track Cell Interactions in Living Bodies
(Stanford School of Medicine) May 6, 2013 - Researchers at Stanford University School of Medicine have developed a new technique to see how different types of cells interact in a living mouse. The process uses light-emitting proteins that glow when two types of cells come close together.
read press release
CU Study Suggests Link Between Tumor Suppressors and Starvation Survival
(University of Colorado) May 9, 2013 - A particular tumor suppressor gene that fights cancer cells does more than clamp down on unabated cell division -- the hallmark of the disease -- it also can help make cells more fit by allowing them to fend off stress, says a University of Colorado Boulder study.
read press release
Discovery Pinpoints Cause of Two Types of Leukemia, Providing Insights Into New Treatment Approach
(Oregon Health & Science University) May 9, 2013 - Research method used by scientists with the Knight Cancer Institute at Oregon Health & Science University shows promise in accelerating advances in personalized cancer medicine.
read press release
India Ranks Number One in Cervical Cancer Deaths
(New York Times/India Ink blog) May 10, 2013 - More women die from cervical cancer every year in India than anywhere else in the world, according to the Cervical Cancer-Free Coalition, an American research and advocacy group that released a 'cervical cancer global crisis card' Friday.
read article
HPV-Related Cancers Rose Before Vaccines Hit Market
(Reuters) May 9, 2013 - The number of some cancers related to the human papillomavirus (HPV) increased throughout the U.S. before vaccines against the sexually transmitted infection were available, says to a new study.
read article
Lilly to Take $30M Charge After Relapse Cancer Drug Disappoints in Trial
(Fox Business) May 10, 2013 - Eli Lilly said Friday it will take a current-quarter charge of $30 million after its exploratory relapse cancer drug enzastaurin failed to meet expectations in a late-stage study.
read article
Reuters Summit: Faster Drug Approvals a Tonic for Pharma Industry
(Reuters) May 8, 2013 - A pickup in new drug approvals, the promise of faster regulatory decisions and more targeted medicines have quickened the pulse of the pharmaceutical industry as a big wave of patent expiries recedes.
read article
U.S. Lawmakers Advance Bill on Prescription Drug Tracking
(CNBC/Reuters) May 8, 2013 - A U.S. House of Representatives panel advanced a bill on Wednesday on how the federal government should track prescription drugs as they move through the distribution chain, over the objections of some Democrats who said the proposal did not go far enough to ensure safety.
read article
GOP Won't Offer Input on Nominees to Controversial ObamaCare Panel
(The Hill/Healthwatch blog) May 9, 2013 - Congressional Republicans are refusing to recommend members for a controversial panel designed to slow the growth of Medicare spending.
read article
Drug Spending Falls for First Time in 6 Decades
(Los Angeles Times) May 9, 2013 - The 1% drop in consumer costs in 2012 is attributed mostly to generics coming onto the market after drug patent expirations, a survey finds.
read article (free registration required)
Biotech's Next Big Thing: ASCO
(TheStreet [video]) May 9, 2013 - TheStreet Sr. Columnist Adam Feuerstein previews the research abstracts presented next week in advance of June's ASCO cancer event.
read article
Opinion: New Cancer Cures Insurers Won’t Cover
(New York Post) May 8, 2013 - Advances in cancer treatment are saving lives and cutting health-care costs. But because many health-insurance plans haven’t caught up with the times, nearly half of all cancer patients are forced to choose between the treatment that could save their lives — or one that’s paid for.
read article
ASCO Responds to SGR Legislation
(ASCO in Action) May 8, 2013 - In a letter to Reps. Joe Heck (R-Nev.) and Allyson Schwartz (D-Pa.), co-sponsors of the Medicare Physician Payment Innovation Act, ASCO applauds the legislation for proposing to repeal the sustainable growth rate and reform the Medicare reimbursement system.
read article
CMS Revises NCCI Edits on CPT Code 96361
(ASCO in Action) May 9, 2013 - Practices who have received a denial for add-on code 96361 will have the opportunity to appeal the denial or resubmit their claims after July 1 due to revisions by the agency.
read article
Eisai USA Foundation to Donate $1 Million to the Conquer Cancer Foundation of the American Society of Clinical Oncology
(Eisai) May 9, 2013 - Eisai USA Foundation Inc., the charitable arm of Eisai Inc., announces that it has pledged a $1 million donation to the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO).
read corporate press release
USF Gets $2.8M NIH Grant with Aetna to Study Genetic Testing and Breast Cancer Treatment
(USF Health) May 9, 2013 - University of South Florida (USF) and Aetna are launching a ground-breaking study that will examine the influence genetic testing may have on clinical treatment decisions among breast cancer patients and their doctors.
read press release
University Receives $2.1 Million for Cancer Research
(George Washington University) May 8, 2013 - The George Washington University Cancer Institute, housed within the School of Medicine and Health Sciences, and School of Public Health and Health Services have received a $2.1 million, three-year research award from the Patient-Centered Outcomes Research Institute to evaluate cancer survivorship care models.
read article
Medicare Lags In Project to Expand Hospice
(Kaiser Health News/Politico Pro) May 9, 2013 - Despite a three-year-old order from Congress, Medicare has yet to begin an experiment to expand hospice services to allow beneficiaries to continue potentially lifesaving treatments to see if it would save money while improving the patients' quality of life.
read article
Chi-Med License Accord for Cancer Drug Probable This Year
(Bloomberg) May 9, 2013 - Hutchison China MediTech Ltd., the drugmaker controlled by Hong Kong billionaire Li Ka-shing, is in talks to license a cancer treatment based on traditional Chinese medicines, Chief Executive Officer Christian Hogg said.
read article
Jennerex Granted FDA Orphan Drug Designation for Pexa-Vec in Hepatocellular Carcinoma (HCC)
(Yahoo! Finance) May 8, 2013 - Top-line data from TRAVERSE, phase 2b Pexa-Vec trial in Hepatocellular Carcinoma, expected at year end.
read article